1 |
Baumann, L. Cosmetic dermatology: Principles & practice. McGraw-Hill, pp 3-8, 2002
|
2 |
Leung, D.Y., Boguniewicz, M., Howell, M.D., Nomura, I., Hamid, Q.A. New insights into atopic dermatitis. J. Clin. Invest. 113: 651-657, 2004
DOI
|
3 |
Trautmann, A., Akdis, M., Schmid-Grendelmeier, P., Disch, R., Brocker, E.B., Blaser, K, Akdis, C.A. Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis. J. Allergy Clin. Immunol. 108: 839-846, 2001
DOI
ScienceOn
|
4 |
Klunker, S., Trautmann, A., Akdis, M., Verhagen, J., Schmid-Grendelmeier, P, Blaser, K, Akdis, C.A. A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN- inducible protein 10, monokine induced by IFN-, and IFN--inducible -chemoattractant for T cell chemotaxis toward epidermis in atopic dermatitis. J. Immunol. 171: 1078-1084, 2003
DOI
|
5 |
Zlontik, A., Yoshie, O. Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127, 2004
DOI
ScienceOn
|
6 |
Kakinuma, T., Nakamura, K., Wakugawa, M., Mitsui, H., Tada, Y., Saeki, H., Torii, H., Asahina, A., Onai, N., Matsushima, K., Tamaki, K. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J. Allergy Clin. Immunol. 107: 535-541, 2001
DOI
ScienceOn
|
7 |
Brandi, M.L. Flavonoids: biochemical effects and therapeutic applications. Bone Miner. 19(Suppl. 1):S3-14, 1992
DOI
ScienceOn
|
8 |
Lim, B.O., Choue, R.W., Lee, H.Y., Seong, N.S., Kim, J.D. Effect of the flavonoid components obtained from Scutellaria radix on the histamine, immunoglobulin E and lipid peroxidation of spleen lymphocytes of Sprague-Dawley rats. Biosci. Biotechnol. Biochem. 67: 1126-1129, 2003
DOI
ScienceOn
|
9 |
Chang, Y.L., Shen, J.J., Wung, B.S., Cheng, J.J., Wang, D.L. Chinese herbal remedy wogonin inhibits monocyte chemotactic protein-1 gene expression in human endothelial cells. Mol. Pharmacol. 60: 507-513, 2001
|
10 |
Lee, S.O., Jeong, Y.J., Yu, M.H., Lee, J.W., Hwangbo, M.H., Kim, C.H., Lee, I.S. Wogonin suppresses TNF-alpha-induced MMP-9 expression by blocking the NF-kappaB activation via MAPK signaling pathways in human aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 351: 118-125, 2006
DOI
ScienceOn
|
11 |
Lee, B.S., Shim, S.M., Heo, J., Pae, H.O., Seo, B.Y., Han, S.Y., Sohn, D.H., Jang, S.I., Chung, H.T. Wogonin suppresses TARC expression induced by mite antigen via heme oxygenase 1 in human keratinocytes. Suppressive effect of wogonin on mite antigen-induced TARC expression. J. Dermatol. Sci. 46: 31-40, 2007
DOI
ScienceOn
|
12 |
Horikawa, T., Nakayama, T., Hikita, I., Yamada, H., Fujisawa, R., Bito, T., Harada, S., Fukunaga, A., Chantry, D., Gray, P.W., Morita, A., Suzuki, R., Tezuka, T., Ichihashi, M., Yoshie, O. IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis. Int. Immunol. 14: 767-773, 2002
DOI
ScienceOn
|
13 |
Komine, M., Kakinuma T., Kagami, S., Hanakawa, Y., Hashimoto, K., Tamaki, K. Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J. Invest. Dermatol. 125: 491-498, 2005
DOI
ScienceOn
|
14 |
Pastore, S., Mascia, F., Mariotti, F., Dattilo, C., Mariani, V., Girolomoni, G. ERK1/2 regulates epidermal chemokine expression and skin inflammation. J. Immunol. 174: 5047-5056, 2005
DOI
|
15 |
Rossi, D., Zlotnik, A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18: 217-242, 2000
DOI
ScienceOn
|
16 |
Imai, T., Baba, M., Nishimura, M., Kakizaki, M., Takagi, S., Yoshie, O. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J. Biol. Chem. 1272: 15036-15042, 1997
|
17 |
Li, Q., Verma, I.M. NF-kappaB regulation in the immune system. Nat. Rev., Immunol. 2: 725-734, 2002
DOI
ScienceOn
|
18 |
Bhat, N.R., Zhang, P., Lee, J.C., Hogan, E.L. Extracellular signal regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18: 1633-1641, 1998
DOI
|
19 |
Chaturvedi, M.M., Mukhopadhyay, A., Aggarwal, B.B. Assay for redoxsensitive transcription factor. Methods Enzymol. 319: 585-602, 2000
DOI
|
20 |
Sallusto, F., Palermo, B., Lenig, D., Miettinen, M., Matikainen, S., Julkunen, I., Forster, R., Burgstahler, R., Lipp, M., Lanzavecchia, A. Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur. J. Immunol. 29: 1617-1625, 1999
DOI
ScienceOn
|
21 |
Akdis, C.A., Akdis, M., Simon, D., Dibbert, B., Weber, M., Gratzl, S., Kreyden, O., Disch, R., Wuthrich, B., Blaser, K., Simon, H.U. T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J. Invest. Dermatol. 113: 628-634, 1999
DOI
ScienceOn
|
22 |
Kobayashi, M., Shimauchi, T., Hino, R., Tokura, Y. Roxithromycin downmodulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: its dual inhibitory effects on the ligands and the receptors. Cell. Immunol. 228: 27-33, 2004
DOI
ScienceOn
|
23 |
Guha, M., Mackman, N. LPS induction of gene expression in human monocytes. Cell. Signal. 13: 85-94, 2001
DOI
ScienceOn
|
24 |
Barnes, P.J., Karin, M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336: 1066-1071, 1997
DOI
ScienceOn
|
25 |
Komine, M., Kakinuma, T, Kagami, S., Hanakawa, Y., Hashimoto, K., Tamaki, K. Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J. Invest. Dermatol. 125: 491-498, 2005
DOI
ScienceOn
|
26 |
Vestergaard, C., Yoneyama, H., Murai, M., Nakamura, K., Tamaki, K., Terashima, Y., Imai, T., Yoshie, O., Irimura, T., Mizutani, H., Matsushima, K. Overexpression of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J. Clin. Invest. 104: 1097-1105, 1999
DOI
ScienceOn
|
27 |
Sandoval-Lopez, G., Teran, L.M. TARC: novel mediator of allergic inflammation. Clin. Exp. Allergy 31: 1809-1812, 2001
DOI
ScienceOn
|
28 |
Zhao, B., Stavchansky, S.A., Bowden, R.A., Bowman, P.D. Effect of interleukin-1beta and tumor necrosis factor-alpha on gene expression in human endothelial cells. Amer. J. Physiol. Cell Physiol. 284: C1577-C1583, 2003
DOI
ScienceOn
|
29 |
Chen, J.C., Ho, F.M., Chao, P.D.L., Chen, C.P., Jeng, K.C., Hsu, H.B., Lee, S.T., Wu, W.T, Lin, W.W. Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IkappaB kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia. Eur. J. Pharmacol. 521: 9-20, 2005
DOI
|
30 |
Nickel, R., Beck, L.A., Stellato, C., Schleimer, R.P. Chemokines and allergic disease. J. Allergy Clin. Immunol. 104: 723-742, 1999
DOI
ScienceOn
|
31 |
Akdis, C.A., Blaser, K., Akdis, M. Apoptosis in tissue inflammation and allergic disease. Curr. Opin. Immunol. 16: 717-723, 2004
DOI
ScienceOn
|
32 |
Thepen, T., Langeveld-Wildschut, E.G., Bihari, I.C., van Wichen, D.F., van Reijsen, F.C., Mudde, G.C., Bruijnzeel-Koomen, C.A. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J. Allergy Clin. Immunol. 97: 828-837, 1996
DOI
ScienceOn
|
33 |
Murphy, P.M., Baggioline, M., Charo, I.F., Hebert, C.A., Horuk, R., Matsushima, K., Miller, K., Miller, L.H., Oppenheim, J.J., Power, C.A. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52: 145-176, 2000
|
34 |
Campbell, J.J., Haraldsen, G., Pan, J., Rottman, J., Qin, S., Ponath, P., Andrew, D.P., Warneke, R., Ruffing, N., Kassam, N., Wu, L., Butcher, E.C. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400: 776-880, 1999
DOI
ScienceOn
|
35 |
Wang, X.C., Jobin, C., Allen, J.B., Roberts,W.L., Jaffe, G.J. Suppression of NF-kappaB-dependent proinflammatory gene expression in human RPE cells by a proteasome inhibitor. Invest. Ophthalmol. Vis. Sci. 40: 477-486, 1999
|
36 |
Ruland, J., Mak, T.W. Transducing signals from antigen receptors to nuclear factor kappaB. Immunol. Rev. 193: 93-100, 2003
DOI
ScienceOn
|
37 |
Bonecchi, R., Bianchi, G., Bordignon, P.P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P.A., Mantovani, A., Sinigaglia, F. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187: 129-134, 1998
DOI
ScienceOn
|
38 |
Jang, S.I., Kim, H.J., Kim, Y.J., Jeong, S.I., You, Y.O. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways. Eur J Pharmacol. 542: 1-7, 2006
DOI
ScienceOn
|
39 |
Galli, G., Chantry, D., Annunziato, F., Romagnani, P., Cosmi, L., Lazzeri, E., Raport, C.J., Galli, G., Manetti, R., Mavilia, C., Vanini, V., Chantry, D., Maggi, E., Romagnani, S. Macrophage-derived chemokine production by activated human T cells in vitro and in vivo: preferential association with the production of type 2 cytokines. Eur. J. Immunol. 30: 204-210, 2000
DOI
ScienceOn
|
40 |
Xiao, Y.Q., Malcolm, K., Worthen, G.S., Gardai, S., Schiemann, W. P.V., Fadok, A., Bratton, D.L., Henson, P.M. Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-beta. J. Biol. Chem. 277: 14884-14893, 2002
DOI
ScienceOn
|
41 |
Trautmann, A., Akdis, M., Kleemann, D., Altznauer, F., Simon, H.U., Graeve, T., Noll, M., Brocker, E.B., Blaser, K., Akdis, C.A. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J. Clin. Invest. 106: 25-35, 2000
DOI
ScienceOn
|
42 |
Vestergaard, C., Bang, K., Gesser, B., Yoneyama, H., Matsushima, K., Larsen, C.G. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. J. Invest. Dermatol. 115: 640-646, 2001
DOI
ScienceOn
|
43 |
Largo, R., Alvarez-Soria, M.A., Diez-Ortego, I, Calvo, E., Sanchez-Pernaute, O., Egido, J., Herrero-Beaumont, G. Glucosamine inhibits IL-1betainduced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartil. 11: 290-298, 2003
DOI
ScienceOn
|
44 |
Imai, T., Chantry, D., Raport, C.J., Wood, C.L., Nishimura, M., Godiska, R., Yoshie, O., Gray, P.W. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J. Biol. Chem. 273: 1764-1768, 1998
DOI
ScienceOn
|
45 |
Lim, B.O. Efficacy of wogonin in the production of immunoglobulins and cytokines by mesenteric lymph node lymphocytes in mouse colitis induced with dextran sulfate sodium. Biosci. Biotechnol. Biochem. 68: 2505-2511, 2004
DOI
ScienceOn
|
46 |
Imai, T., Baba, M., Nishimura, M., Kakizaki, M., Nishimura, M., Wang, J., Gray, P., Matsushima, K., Yoshie, O. Selective recruitment of CCR4bearing Th2 cells toward antigen-presenting cells by the CC chemokine thymus and activationregulated chemokine and macrophage-derived chemokine. Int. Immunol. 11: 81-88, 1999
DOI
ScienceOn
|